NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Cap table

NeuroSense Therapeutics Ltd.

Cap table

Built by 6ix from NeuroSense Therapeutics Ltd.’s releases · as of Apr 28, 2026

Common shares
1,896,902
Fully diluted
1,896,902

Fully diluted

LineShares
Common shares1,896,902

Warrants and options

Lot
Warrants · US$1.25 · expire about Dec 2029

Share count over time

CountShares
Nov 22, 20261,896,902